Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
GRANDTECH
835184
Doushen(Beijing) Education & Technology Inc.
300010
CN Stock MarketDetailed Quotes
000078 Shenzhen Neptunus Bioengineering
- 2.34
- -0.08-3.31%
Not Open Jan 23 15:00 CST
6.16BMarket Cap-3.56P/E (TTM)
2.40High2.31Low349.91KlotVolume2.31Open2.42Pre Close82.33MTurnover1.33%Turnover RatioLossP/E (Static)2.63BShares3.1952wk High2.03P/B6.15BFloat Cap2.0152wk Low2.66Limit Up2.63BShs Float14.30Historical High2.18Limit Down3.72%Amplitude0.40Historical Low--Dividend TTM2.35Avg Price178.98KlotAsk--Div YieldTTM100Lot Size166.69KlotBid
Shenzhen Neptunus Bioengineering News
Neptune Biotech: Announcement on transfer of part of the accounts receivable from subsidiaries
Neptune Biotech: Announcement on the progress of transferring accounts receivable from some of its subsidiaries
Neptune Biotech: Announcement on transfer of part of the accounts receivable from subsidiaries
Neptune Biotech: Additional commitment on bill financing issues
Neptune Biotech: Voluntary Information Disclosure Notice Concerning All Payable Bonds in 2020 Have Been Repaid on Time
Neptune Biotech: Voluntary Information Disclosure Notice on Repayment of the First Issue of 2017 Interim Notes
Neptune Biotech: 2020 Tracking Rating Report for Company Entities and Related Debts
Neptune Biotech: 2017 Public Issuance of Corporate Bonds to Qualified Investors (Phase I) 2020 Principal and Interest Payment and Delisting Notice
Neptune Biotech: Announcement on Proposed Non-public Issuance of Short-Term Corporate Bonds (Epidemic Prevention and Control Bonds) Plans
Neptune Biotech: Announcement on plans to publicly issue corporate bonds (epidemic prevention and control bonds)
Neptune Biotech: 2017 Public Issuance of Corporate Bonds to Qualified Investors Second Interim Report on Fiduciary Management Matters in 2019
Neptune Biotech: Announcement on transfer of part of the accounts receivable from subsidiaries
Neptune Biotech: Announcement on the completion of 2019 interest payments on the first instalment of the 2017 medium-term notes
Neptune Biotech: 2019 Annual Tracking Rating Report for Subjects and Related Debts
Neptune Biotech: Announcement on “17 Neptune 01” investor resale results
Neptune Biotech: 2017 Public Offering of Corporate Bonds to Qualified Investors (Phase I) 2019 Interest Payment Announcement
Neptune Biotech: Announcement on “17 Neptune 01” investors' resale declarations
Neptune Biotech: Third indicative announcement on the “17 Neptune 01” coupon interest rate adjustment and investor resale implementation measures
Neptune Biotech: Second indicative announcement on the “17 Neptune 01” coupon interest rate adjustment and investor resale implementation measures
Neptune Biotech: First indicative announcement on the “17 Neptune 01” coupon interest rate adjustment and investor resale implementation measures
